CHRISTOPHER STUBBS • Discovery Biology, Discovery Sciences, IMED Biotech Unit,
AstraZeneca, Cambridge, UK
TERENCE T. L. TANG • MRC Laboratory of Molecular Biology, Cambridge, UK
SHIH-CHIA TSO • Departments of Biophysics and Microbiology, UT Southwestern Medical
Center, Dallas, TX, USA
ANDREW P. TURNBULL • Cancer Research UK Therapeutic Discovery Laboratories, London
Bioscience Innovation Centre, London, UK
STEPHAN UEBEL • Max-Planck-Institut fu ¨r Biochemie, Martinsried, Germany
HANS-JOACHIM WIEDEN • Department of Chemistry and Biochemistry, Alberta RNA
Research and Training Institute (ARRTI), University of Lethbridge, Lethbridge,
AB, Canada
XIAOQIU WU • Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals
R&D, AstraZeneca, Gothenburg, Sweden
LUDOVIT ZWEIFEL • Biophysics Facility, Biozentrum, University of Basel, Basel, Switzerland
Contributors
xi